🇪🇸 Spain · EU Public Tender
Suministro de los principios activos denominados "Emicizumab 105 MG / 0,7 ML vialinyectable", "Emicizumab 150 MG / 1 ML vial inyectable" Y "Emicizumab 60 MG / 0,4 ML vial inyectable".
🏛️ Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín · 📍 Las Palmas de Gran Canaria
320 K€
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33690000 |
| Awarded to | ROCHE FARMA, S.A. |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.